Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT04074408
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT04074408
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04074408. Randomized; single masking; primary purpose treatment. Start 2020-05 (anticipated); primary completion 2022-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intracavitary Injection of hUMSCs in Acute Basal Ganglia Hematoma After Stereotactic Aspiration
- Condition
- Basal Ganglia Hematoma
- Intervention (Procedure)
- stereotactic surgery
- Intervention (Biological)
- hUMSCs
- Intervention (Biological)
- placebo
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Collaborator
- The First Affiliated Hospital, University of Science and Technology of China
- Collaborator
- Zhejiang University
- Collaborator
- First Affiliated Hospital of Fujian Medical University
- Collaborator
- Jinhua Hospital, School of Medicine, Zhejiang University
- Collaborator
- Taizhou Hospital
Record details
- Record id
cardio:ct-nct04074408- Content hash
1547106ae95a16cdf58122734f12e2c3b29891fad23f456a364bab5bd60db46c